When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of three days per week from the office. But that doesn’t mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
Introduction to role
Are you ready to lead the charge in pharmacometrics? As a Senior Manager in Clinical Pharmacology and Quantitative Pharmacology (CPQP), you will be at the forefront of PK-PD Modeling and Pharmacometrics (PMX). Your task involves developing and implementing Modeling & Simulation (M&S) plans and strategies, guiding compounds from early-stage trials to post-market phases. Collaborate with cross-functional teams within Alexion R&D, including Clinical Pharmacology, Translational Medicine, and Biostatistics, to enhance our PMX capabilities.
Your expertise will drive the continuous improvement of pharmacometrics skills, computational infrastructure, and strategic M&S methodologies across diverse projects and disease areas. Take charge of project-related M&S assignments, whether independently or in collaboration with external PMX CROs. Are you ready to make a difference?
Accountabilities
Lead M&S strategies/plans as a project leader in cross-functional development teams.Apply brand new M&S methodologies to inform decision-making at crucial achievements.Build quantitative systems biology/pharmacology models with internal teams and external QSP service providers.Conduct population PK, PKPD analyses, clinical trial simulations, and model-based analyses.Initiate and coordinate outsourced M&S activities.Mentor and coach junior M&S scientists and CPQP scientists.Enhance Alexion's internal M&S capabilities through training and new tool evaluation.Prepare population PK/PD reports and regulatory submission documents.Essential Skills/Experience
PhD or equivalent experience in quantitative sciences2+ years of pharmaceutical industrial and/or postdoctoral experience in the related teams of clinical pharmacology, PKPD, and QSPExcellent hands-on knowledge in R and/or SAS, NONMEMExcellent knowledge in Matlab, Mathematica, or other QSP related software or computing platformUnder manager’s guidance, to become well versed at analyzing, summarizing, plotting complex data to identify trends important for drug developmentTrack record of applying quantitative system pharmacology methodologies in a drug R&D contextTrack record of publishing M&S workExperience from PMX approaches in hematology, nephrology, neuromuscular, ophthalmology, bone, endocrinology, oncology, and/or metabolic rare diseases preferredExcellent written and verbal communication skillsDesirable Skills/Experience
Doctoral degree (PhD or Equivalent training by experience) in clinical pharmacology, pharmacology/cell biology/immunology, or relevant fieldBackground in clinical pharmacology or bioengineering is desiredAt Alexion, you will find a collaborative culture that encourages innovation and a diverse environment where your contributions are valued. You will have the opportunity to be at the forefront of rare disease research and make a meaningful difference in patients' lives.
Ready to lead and inspire? Apply now and take the first step towards a fulfilling career at Alexion, AstraZeneca Rare Disease.
#LI-Hybrid
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.